Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Integrins in human hepatocellular carcinoma tumorigenesis and therapy. | Chin Med J (Engl) | 2023 | 36848180 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus. | Clin Med Insights Endocrinol Diabetes | 2023 | 36844983 | PubTator, text mining | PubMed |
| The role of the NDRG1 in the pathogenesis and treatment of breast cancer. | Biochim Biophys Acta Rev Cancer | 2023 | 36841367 | PubTator, text mining | PubMed |
| Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer. | Int J Mol Sci | 2023 | 36835564 | PubTator, text mining | PubMed |
| New Insights into the Regulation of mTOR Signaling via Ca2+-Binding Proteins. | Int J Mol Sci | 2023 | 36835331 | PubTator, text mining | PubMed |
| ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. | Int J Mol Sci | 2023 | 36835157 | PubTator, text mining | PubMed |
| Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells. | Cancers (Basel) | 2023 | 36831670 | PubTator, text mining | PubMed |
| Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy. | Cancers (Basel) | 2023 | 36831579 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. | Cancers (Basel) | 2023 | 36831450 | PubTator, text mining | PubMed |
| Loss of Tumor Suppressor C9orf9 Promotes Metastasis in Colorectal Cancer. | Biomolecules | 2023 | 36830681 | PubTator, text mining | PubMed |
| Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia. | Breast Cancer Res Treat | 2023 | 36826702 | PubTator, text mining | PubMed |
| Monitoring of Sleep Breathing States Based on Audio Sensor Utilizing Mel-Scale Features in Home Healthcare. | J Healthc Eng | 2023 | 36818388 | PubTator, text mining | PubMed |
| PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway. | Front Oncol | 2023 | 36816970 | PubTator, text mining | PubMed |
| Alphaherpesvirus upregulates NDRG1 expression to facilitate the nuclear import of viral UL31 and UL34 proteins. | J Med Virol | 2023 | 36807585 | PubTator, text mining | PubMed |
| Excessive iodine induces thyroid follicular epithelial cells apoptosis by activating HIF-1α-mediated hypoxia pathway in Hashimoto thyroiditis. | Mol Biol Rep | 2023 | 36807042 | PubTator, text mining | PubMed |
| Endothelial Indoleamine-2,3-Dioxygenase-1 is not Critically Involved in Regulating Antitumor Immunity in the Central Nervous System. | Int J Tryptophan Res | 2023 | 36798537 | PubTator, text mining | PubMed |
| Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets. | Front Endocrinol (Lausanne) | 2023 | 36793283 | PubTator, text mining | PubMed |
| High diagnostic yield with algorithmic molecular approach on hereditary neuropathies. | Rev Assoc Med Bras (1992) | 2023 | 36790232 | PubTator, text mining | PubMed |
| A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle. | Molecules | 2023 | 36770809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=22